167 related articles for article (PubMed ID: 8331772)
21. [In vitro studies on the combined effects of arbekacin and fosfomycin on methicillin-resistant Staphylococcus aureus].
Watanabe T; Kanno M; Sobu K; Takase Y; Yoshida T
Jpn J Antibiot; 1995 Feb; 48(2):284-92. PubMed ID: 7745817
[TBL] [Abstract][Full Text] [Related]
22. [Synergistic action of cefodizime and other antimicrobial agents on clinically isolated microorganisms. I. Synergistic action with minocycline].
Deguchi K; Yokota N; Koguchi M; Nakane Y; Suzuki Y; Fukayama S; Ishihara R
Jpn J Antibiot; 1991 Dec; 44(12):1386-91. PubMed ID: 1798073
[TBL] [Abstract][Full Text] [Related]
23. [Antimicrobial activities of arbekacin against methicillin-resistant Staphylococcus aureus isolated from patients of a pediatrics ward].
Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1993 Sep; 46(9):794-800. PubMed ID: 8254899
[TBL] [Abstract][Full Text] [Related]
24. [Combination effect of arbekacin and cefepime on mixed culture of MRSA and P. aeruginosa].
Araake M; Hara T; Miyata A; Tani M; Ogawa H
Jpn J Antibiot; 2001 Feb; 54(2):69-78. PubMed ID: 11338680
[TBL] [Abstract][Full Text] [Related]
25. Enhancement of antimicrobial effects of various antibiotics against methicillin-resistant Staphylococcus aureus (MRSA) by combination with fosfomycin.
Nakazawa H; Kikuchi Y; Honda T; Isago T; Nozaki M
J Infect Chemother; 2003 Dec; 9(4):304-9. PubMed ID: 14691650
[TBL] [Abstract][Full Text] [Related]
26. [Antibacteriological activities of arbekacin and vancomycin against strains of MRSA].
Ishii T; Takayama Y; Takase Y; Orikasa Y
Jpn J Antibiot; 1994 Jun; 47(6):647-54. PubMed ID: 8072173
[TBL] [Abstract][Full Text] [Related]
27. Bactericidal activity of arbekacin against methicillin-resistant Staphylococcus aureus. Comparison with that of vancomycin.
Aoki Y
Jpn J Antibiot; 1994 Jun; 47(6):640-6. PubMed ID: 8072172
[TBL] [Abstract][Full Text] [Related]
28. [Development of arbekacin and synthesis of new derivatives stable to enzymatic modifications by methicillin-resistant Staphylococcus aureus].
Kondo S
Jpn J Antibiot; 1994 Jun; 47(6):561-74. PubMed ID: 8072163
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy of arbekacin, a new aminoglycoside antibiotic, in surgical patients with MRSA infections].
Ishikawa S; Yura J; Shinagawa N; Mizuno A; Mashita K; Hori K
Jpn J Antibiot; 1994 Jun; 47(6):820-5. PubMed ID: 8072192
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the activity and effects of combinations of various antibacterial agents against methicillin-resistant Staphylococcus aureus in vitro].
Kouda M; Homma S; Udagawa I; Fukuhara J; Takeuchi M; Tamura K
Jpn J Antibiot; 2000 Mar; 53(3):171-8. PubMed ID: 10834148
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between arbekacin-susceptibility and aminoglycoside-resistant gene of methicillin-resistant Staphylococcus aureus (MRSA)].
Tabata M; Shimizu M; Araake M; Ogawa H
Jpn J Antibiot; 2003 Feb; 56(1):36-43. PubMed ID: 12723397
[TBL] [Abstract][Full Text] [Related]
32. Efficacies of vancomycin, arbekacin, and gentamicin alone or in combination against methicillin-resistant Staphylococcus aureus in an in vitro infective endocarditis model.
Lee DG; Chun HS; Yim DS; Choi SM; Choi JH; Yoo JH; Shin WS; Kang MW
Antimicrob Agents Chemother; 2003 Dec; 47(12):3768-73. PubMed ID: 14638480
[TBL] [Abstract][Full Text] [Related]
33. [Epidemiological study of Arbekacin-resistant, methicillin resistant Staphylococcus aureus in Saitama Medical School Hospital].
Yamazaki T; Endo K; Tominaga K; Fukuda M; Maesaki S; Hashikita G; Itabashi A
Kansenshogaku Zasshi; 2004 Apr; 78(4):305-11. PubMed ID: 15176234
[TBL] [Abstract][Full Text] [Related]
34. [Necessity and usefulness of detection by PCR of mecA and aac(6')/aph(2") genes for identification of arbekacin-resistant MRSA].
Hotta K; Ishikawa J; Ishii R; Saitoh F; Kira K; Arakawa Y; Ike Y
Jpn J Antibiot; 1999 Aug; 52(8):525-32. PubMed ID: 10587877
[TBL] [Abstract][Full Text] [Related]
35. [Clinical efficacy of arbekacin in patients with methicillin-resistant Staphylococcus aureus infections. Research Group of MRSA Forum].
Nasuhara K; Takatsuka K; Takatsuka N; Teraoka M; Tokita S; Shinohara M; Azuma E; Saijo N; Sone H; Saito I
Jpn J Antibiot; 1994 Jun; 47(6):720-30. PubMed ID: 8072180
[TBL] [Abstract][Full Text] [Related]
36. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1996)].
Ikemoto H; Watanabe K; Mori T; Igari J; Oguri T; Shimizu Y; Terai T; Inoue H; Nakadate T; Ito C; Yoshida T; Ohno I; Tanno Y; Arakawa M; Igarashi K; Okada M; Ozaki K; Aoki N; Kitamura N; Sekine O; Suzuki Y; Nakata K; Nakatani T; Inagawa H; Kusano N
Jpn J Antibiot; 1998 Jul; 51(7):437-74. PubMed ID: 9755430
[TBL] [Abstract][Full Text] [Related]
37. [Antibacterial activities of combination uses of isepamicin and beta-lactams in vitro against clinically isolated strains. Part 1. Activities against Staphylococcus aureus].
Deguchi K; Koguchi M; Suzuki Y; Tanaka S; Fukayama S; Ishihara R; Oda S
Jpn J Antibiot; 1996 Feb; 49(2):194-202. PubMed ID: 8721079
[TBL] [Abstract][Full Text] [Related]
38. A possible immunomodulating activity of arbekacin (ABK), a newly synthesized antibiotic against methicillin-resistant Staphylococcus aureus (MRSA).
Okai Y; Ishizaka S
Int J Immunopharmacol; 1994 Apr; 16(4):321-7. PubMed ID: 8045672
[TBL] [Abstract][Full Text] [Related]
39. Structures of enzymatically modified products of arbekacin by methicillin-resistant. Staphylococcus aureus.
Kondo S; Tamura A; Gomi S; Ikeda Y; Takeuchi T; Mitsuhashi S
J Antibiot (Tokyo); 1993 Feb; 46(2):310-5. PubMed ID: 8468247
[TBL] [Abstract][Full Text] [Related]
40. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. IV. Aminoglycoside-modifying enzyme AAC(6')/APH(2") is responsible for arbekacin-resistance enhanced by bleomycin.
Inouye Y; Hashimoto M; Sugiyama M; Takesue Y; Santo T; Yokoyama T
Hiroshima J Med Sci; 1994 Sep; 43(3):87-92. PubMed ID: 7534753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
